Disruption of β-arrestins blocks glucocorticoid receptor and severely retards lung and liver development in mice

Area of Science:

• Developmental biology
• Molecular signaling
• Genetics

Background:

• Beta-arrestins (β-arrestin 1 and β-arrestin 2) are key regulators of G protein-coupled receptor signaling.
• Their specific roles in fetal organogenesis, particularly lung and liver development, remain incompletely understood.

Purpose of the Study:

• To investigate the function of β-arrestin 1 and β-arrestin 2 in fetal lung and liver development.
• To elucidate the relationship between β-arrestins and glucocorticoid receptor (GR) signaling in these organs.

Main Methods:

• Utilized dual-null Arrb1(-/-)Arrb2(-/-) mouse embryos for genetic analysis.
• Employed morphological examination, Western blot, and immunofluorescence to assess organ development and protein expression.
• Measured hepatic glucose production and gluconeogenic enzyme mRNA levels.

Main Results:

• Arrb1(-/-)Arrb2(-/-) mouse embryos exhibited pulmonary hypoplasia and hepatic impairment, leading to perinatal death.
• Significantly reduced glucocorticoid receptor (GR) protein levels were observed in the lungs and livers of dual-null embryos.
• Hepatic glucose production and gluconeogenic enzyme expression were markedly decreased in the absence of β-arrestin 1/2.

Conclusions:

• β-arrestin 1 and β-arrestin 2 play a critical role in fetal lung and liver development, likely through an indirect regulation of GR.
• GR appears to be an important downstream mediator of β-arrestin signaling in the development of these organs.
• The findings suggest a complex, indirect regulatory pathway involving β-arrestins and GR in organogenesis.